Reaction of UO2(dbm)2(THF) (dbm = OC(Ph)CHC(Ph)O) with 1 equiv. of R3SiH (R = Ph, Et), in the presence of B(C6F5)3, results in the formation of U(OB{C6F5}3)(OSiR3)(dbm)2(THF) (R = Ph, 1; Et, 2), which were isolated as red-orange crystalline solids in good yields. Interestingly, the addition of 1 equiv. of H(dbm) to 2 results in protonation of the –OSiEt3 ligand and formation of U(OB{C6F5}3)(dbm)3 (4) in 33% yield, along with formation of HOSiEt3. Furthermore, addition of HOSiEt3 and 1 equiv. of THF to 4, results in the formation 2, revealing that this process is reversible. The two-step conversion of UO2(dbm)2(THF) to 4 represents a rare example of controlled uranyl oxo ligand cleavage at ambient temperature and pressure. Comparison of diffraction and density functional theory data for 4 suggests the presence of the inverse trans influence, with a very shallow potential energy well for distortion along the trans U–O bond.
No takes yet. Share an insight, caveat, or question.
Pedrick et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: